Lifecore Biomedical, Inc. LFCR
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 05/25/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.16M | -14.98M | -9.99M | -9.99M | -1.15M |
| Total Depreciation and Amortization | 2.52M | 2.31M | 1.98M | 1.98M | 1.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.98M | 11.89M | 9.13M | 9.13M | 5.61M |
| Change in Net Operating Assets | -8.53M | 5.48M | 638.00K | 638.00K | -1.03M |
| Cash from Operations | -2.19M | 4.70M | 1.76M | 1.76M | 5.35M |
| Capital Expenditure | -513.00K | -1.12M | -1.74M | -1.74M | -2.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -513.00K | -1.12M | -1.74M | -1.74M | -2.10M |
| Total Debt Issued | 28.00M | 36.40M | 12.10M | 12.10M | 128.57M |
| Total Debt Repaid | -28.00M | -36.40M | -12.33M | -12.33M | -127.87M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -614.00K | -- | -1.16M | -1.16M | -171.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -238.00K | -256.00K | -- | -- | -930.00K |
| Cash from Financing | -852.00K | -256.00K | -1.39M | -1.39M | -402.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.55M | 3.33M | -1.36M | -1.36M | 2.85M |